Harmony Biosciences Holdings, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
![]() EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
![]() FENC
Fennec Pharmaceuticals Inc. |
$6.08 | $187.43 M | 171.5 | 29 | $21.25 M |
![]() GOSS
Gossamer Bio, Inc. |
$1.09 | $124.06 M | -0.65 | 135 | $0 |
![]() GPCR
Structure Therapeutics Inc. |
$27.50 | $2.47 B | -23.59 | 163 | $0 |
![]() IDYA
IDEAYA Biosciences, Inc. |
$25.69 | $2.88 B | -19 | 131 | $7.00 M |
![]() INZY
Inozyme Pharma, Inc. |
$2.89 | $286.39 M | -3.43 | 67 | $0 |
![]() JANX
Janux Therapeutics, Inc. |
$53.49 | $2.29 B | -36.8 | 81 | $10.59 M |
![]() KRON
Kronos Bio, Inc. |
$0.97 | $44.62 M | -0.37 | 62 | $6.29 M |
![]() KROS
Keros Therapeutics, Inc. |
$15.64 | $1.76 B | -9.45 | 169 | $3.55 M |
![]() LYRA
Lyra Therapeutics, Inc. |
$0.22 | $19.53 M | -0.27 | 88 | $1.56 M |
![]() NUVL
Nuvalent, Inc. |
$78.09 | $5.11 B | -32.72 | 142 | $0 |
![]() NVCT
Nuvectis Pharma, Inc. |
$6.61 | $116.38 M | -4.5 | 13 | $0 |
![]() PLRX
Pliant Therapeutics, Inc. |
$13.18 | $672.63 M | -3.9 | 171 | $0 |
![]() PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
![]() REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
![]() RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
![]() SNDX
Syndax Pharmaceuticals, Inc. |
$13.69 | $1.66 B | -6.02 | 270 | $23.68 M |
![]() TVTX
Travere Therapeutics, Inc. |
$18.71 | $542.80 M | -1.32 | 385 | $233.18 M |
![]() VRDN
Viridian Therapeutics, Inc. |
$20.07 | $776.72 M | -2.71 | 143 | $302,000 |
![]() VRNA
Verona Pharma plc |
$44.81 | $983.52 M | -15.16 | 209 | $42.28 M |
![]() VTYX
Ventyx Biosciences, Inc. |
$2.42 | $229.83 M | -1.01 | 79 | $0 |